Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 2
2010 1
2012 3
2013 3
2014 4
2015 5
2016 5
2017 2
2018 4
2019 4
2020 6
2021 7
2022 10
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria.
Neuen BL, Heerspink HJL, Vart P, Claggett BL, Fletcher RA, Arnott C, de Oliveira Costa J, Falster MO, Pearson SA, Mahaffey KW, Neal B, Agarwal R, Bakris G, Perkovic V, Solomon SD, Vaduganathan M. Neuen BL, et al. Among authors: falster mo. Circulation. 2024 Feb 6;149(6):450-462. doi: 10.1161/CIRCULATIONAHA.123.067584. Epub 2023 Nov 12. Circulation. 2024. PMID: 37952217
Persistence and Adherence to Cardiovascular Medicines in Australia.
de Oliveira Costa J, Lin J, Pearson SA, Buckley NA, Schaffer AL, Falster MO. de Oliveira Costa J, et al. Among authors: falster mo. J Am Heart Assoc. 2023 Jul 4;12(13):e030264. doi: 10.1161/JAHA.122.030264. Epub 2023 Jun 29. J Am Heart Assoc. 2023. PMID: 37382104 Free PMC article.
Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) in Australia in the era of increased evidence of their cardiovascular benefits (2014-2022).
Lin J, Pearson SA, Greenfield JR, Park KH, Havard A, Brieger D, Day RO, Falster MO, de Oliveira Costa J. Lin J, et al. Among authors: falster mo. Eur J Clin Pharmacol. 2023 Sep;79(9):1239-1248. doi: 10.1007/s00228-023-03539-8. Epub 2023 Jul 14. Eur J Clin Pharmacol. 2023. PMID: 37449993 Free PMC article.
59 results